News

Filter

Current filters:

GlaxoSmithKlineBenlysta

226 to 235 of 96601 results

US FDA grants Fast Track status to BrainStorm Cell Therapeutics for ALS treatment NurOwn

US FDA grants Fast Track status to BrainStorm Cell Therapeutics for ALS treatment NurOwn

07-10-2014

The US Food and Drug Administration has designated a product from stem cell treatment developer BrainStorm…

BiotechnologyBrainStorm Cell TherapeuticsNeurologicalNurOwnRegulationUSA

Teva to drop 14 pipeline projects as it refocuses

Teva to drop 14 pipeline projects as it refocuses

07-10-2014

Israeli generics giant Teva Pharmaceutical Industries has concluded an extensive evaluation of its current…

CopaxoneIsraelManagementNeurologicalOncologyPharmaceuticalRespiratory and PulmonaryTevaWomen's Health

Novartis and Bristol-Myers Squibb sign NSCLC collaboration

Novartis and Bristol-Myers Squibb sign NSCLC collaboration

07-10-2014

Swiss drug major Novartis and US peer Bristol-Myers Squibb have announced a clinical collaboration to…

Bristol-Myers SquibbNovartisOncologyOpdivoPharmaceuticalResearchUSAZykadia

Alcobra shares fall on Phase III results of ADHD drug

Alcobra shares fall on Phase III results of ADHD drug

07-10-2014

Shares of Israeli emerging biopharmaceutical company Alcobra lost nearly half their market value after…

AlcobraIsraelMetadoxineNeurologicalPharmaceuticalResearch

Sunesis’ Phase III trial in AML fails to meet primary endpoint

Sunesis’ Phase III trial in AML fails to meet primary endpoint

07-10-2014

USA-based Sunesis Pharmaceuticals says that its pivotal Phase III trial of vosaroxin and cytarabine in…

CytarabineOncologyPharmaceuticalQinprezoResearchSunesis PharmaceuticalsUSAvosaroxin

Merck Serono links with ICR and Wellcome Trust on anti-cancer drugs

Merck Serono links with ICR and Wellcome Trust on anti-cancer drugs

07-10-2014

German life sciences major Merck KGaA says its biopharma division Merck Serono has entered into a co-development…

BiotechnologyGermanyLicensingMerck KGaAMerck SeronoOncologyResearch

Regeneron gains further FDA indications for Eylea

Regeneron gains further FDA indications for Eylea

07-10-2014

The US Food and Drug Administration has approved biotech firm Regeneron Pharmaceuticals’ Eylea (aflibercept)…

BayerBiotechnologyEyleaOphthalmicsRegeneron PharmaceuticalsRegulationUSA

226 to 235 of 96601 results

Back to top